About PHARMCUBE Media
We have built four information modules across the pharmaceutical industry chain, covering
research fronts, venture capital, industry analysis, and medical research, and have successfully
established ourselves as a leading media brand with our services, including original articles, visualization business, webinars, and events.
So far, we have over 800,000 specialized readers and served more than 300 companies.
Original Articles
Focus on biopharma research fronts Gain insight into investment trends
Track industry development Witness clinical advancements
Based on our in-house data and analysis edges, we deliver specialized content with unprecedented efficiency.
查看文章
医药魔方
行业趋势分析
市场格局洞察
热点政策解读
公司业务透视
重要人物专访
医药魔方Pro
新靶点/技术/疗法
早期项目开发进展
早期医药投资趋势
专家点评解读
医药魔方Invest
一二级投融资情报
资本市场动态
经典创投案例分析
标杆创投人物故事
医药魔方Info
药品研发情报
交易合作动态
公司业绩扫描
行业政策速递
人才流动快报
医药魔方Med
重磅临床结果
临床试验方法
疾病治疗突破
临床指南共识
临床专家访谈
Webinars & Events
We hold conversations with top experts on topics in focus, exchange thoughts, and gain insights.
直播回放 2022-11-02魔方的朋友们 | 减重药物,研发投资布局正当时?
肥胖、集采、消费趋势叠加,市场需求庞大,“顶流”司美格鲁肽已率先发力,减肥药是否将要成为下一个风口+蓝海?哪些药企能抓住国内的减肥药市场机会?
直播回放 2022-10-13特色CXO | 如何尽可能增加创新药临床价值和国际化机会
中国创新药企在出海路上,如何利用CRO经验与建议?中国医药产业如何提升临床研发效率,抓住机会扩大创新药国际化窗口?
直播回放 2022-09-26魔方学苑 | PROTAC研发能力:从化学合成到体外生物学评估
靶向“不可成药”靶点,PROTAC技术或将出现下一个重磅药物。进入临床转化时代,如何才能高效研发?